#CollinsConclusion

#CollinsConclusions -DLBCL1Drugs v cells:• bispecifics come of age- CRR~ 50% DLBCL- step up dosing & subcut CRS- 1L elderly safe & active- v little neurotox• CART- 1L high risk
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.